You are here: Industry Insights > CDMO

News List

CPhI Monthly Podcast: Selecting the Right CDMO Outsourcing Partner cphi-online
September 13, 2021
Sponsors within the biopharmaceutical industry are increasingly turning to outsourcing for several reasons; remaining competitive and flexible within a quickly evolving sector...
Room for specialists and one-stop-shops in CDMO space prnewswire
September 13, 2021
In general, contractors try to meet these demands either by offering a broad range of services, covering everything from process development through to fill-finish – so-called “one-stop-shops” - or they specialize in an effort to carve out a niche.
Emerging regional markets show promise as CDMO globalisation trend grows cphi-online
September 08, 2021
This is the consensus view of experts in the biopharmaceutical outsourcing sector who say the pace of growth is showing no signs of slowing down.
Recipharm expands its analytical services offering in India cphi-online
August 26, 2021
The CDMO inaugurates its new analytical laboratory under Recipharm Analytical Solutions
Curia lays out plans to expand complex API manufacturing capacity cphi-online
August 23, 2021
The $35 million investment will more than double the site’s batch-size scaling and product output.
Cell and gene therapy manufacturing services market to value $13.8 billion by 2026 europeanpharmaceuticalreview
August 12, 2021
The global cell and gene therapy manufacturing services market is expected to grow at a CAGR of 12.4 percent in the next five years.
Recro eyes expansion to full-service CDMO status cphi-online
August 12, 2021
The solid oral dose specialist signs letter of intent for acquisition of a CDMO providing a full range of services
TriRx Completes Acquisition of Elanco Animal Health Facility contractpharma
August 09, 2021
Site in Shawnee, KS to become a global center of excellence serving the pharmaceutical contract development and manufacturing market.
GRAM Expands Footprint with New Finishing Center contractpharma
August 09, 2021
New 110,000 sq.-ft. finishing center is the injectable CDMO's fourth GMP manufacturing facility.
Global API CDMO market to value almost $140bn by 2028 europeanpharmaceuticalreview
August 06, 2021
Market research suggests the Asia Pacific region could soon overtake Europe and North America in the active pharmaceutical ingredient (API) contract development and manufacturing organisation (CDMO) market.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page